Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Clin Exp Immunol ; 179(1): 24-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24611549

ABSTRACT

Coordinated programmes of resolution are thought to initiate early after an inflammatory response begins, actively terminating leucocyte recruitment, allowing their demise via apoptosis and their clearance by phagocytosis. In this review we describe an event that could be implicated in the resolution of inflammation, i.e. the establishment of a refractory state in human neutrophils that had phagocytosed apoptotic cells. Adherent neutrophils challenged with apoptotic cells generate neutrophil extracellular traps (NETs), filaments of decondensed chromatin decorated with bioactive molecules that are involved in the capture of various microbes and in persistent sterile inflammation. In contrast, neutrophils that had previously phagocytosed apoptotic cells lose their capacity to up-regulate ß2 integrins and to respond to activating stimuli that induce NET generation, such as interleukin (IL)-8. A defective regulation of NET generation might contribute to the persistent inflammation and tissue injury in diseases in which the clearance of apoptotic cells is jeopardized, including systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.


Subject(s)
Apoptosis/immunology , Extracellular Traps/immunology , Neutrophils/immunology , Phagocytosis/immunology , CD18 Antigens/metabolism , Cell Line , Cell Membrane/metabolism , Humans , Neutrophils/metabolism
2.
J Thromb Haemost ; 12(12): 2074-88, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25163512

ABSTRACT

BACKGROUND: Increasing evidence implicates both platelets and neutrophils in the formation, stabilization, and growth of peripheral and coronary thrombi. Neutrophil extracellular traps (NETs) play a key role. The early events in the deregulated cross-talk between platelets and neutrophils are poorly characterized. OBJECTIVES: To identify at the molecular level the mechanism through which platelets induce the generation of NETs in sterile conditions. PATIENTS/METHODS: The presence of NETs was determined in 26 thrombi from patients with acute myocardial infarction by immunohistochemistry and immunofluorescence and markers of NETs assessed in the plasma. In vitro NET generation was studied in static and in physiological flow conditions. RESULTS: Coronary thrombi mainly consist of activated platelets, neutrophils, and NETs in close proximity of platelets. Activated platelets commit neutrophils to NET generation. The event abates in the presence of competitive antagonists of the high mobility group box 1 (HMGB1) protein. Hmgb1(-/-) platelets fail to elicit NETs, whereas the HMGB1 alone commits neutrophils to NET generation. Integrity of the HMGB1 receptor, Receptor for Advanced Glycation End products (RAGE), is required for NET formation, as assessed using pharmacologic and genetic tools. Exposure to HMGB1 prevents depletion of mitochondrial potential, induces autophagosome formation, and prolongs neutrophil survival. These metabolic effects are caused by the activation of autophagy. Blockade of the autophagic flux reverts platelet HMGB1-elicited NET generation. CONCLUSIONS: Activated platelets present HMGB1 to neutrophils and commit them to autophagy and NET generation. This chain of events may be responsible for some types of thromboinflammatory lesions and indicates novel paths for molecular intervention.


Subject(s)
Autophagy , Extracellular Traps/metabolism , HMGB1 Protein/genetics , Neutrophils/cytology , Platelet Activation , Adult , Aged , Animals , Antibodies, Monoclonal/chemistry , Blood Platelets/cytology , Bone Marrow Cells/cytology , Case-Control Studies , Humans , Immunity, Innate , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Mitochondria/pathology , Reactive Oxygen Species/metabolism , Thrombosis/blood , Thrombosis/pathology
3.
Clin Exp Immunol ; 175(2): 150-66, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24128276

ABSTRACT

Vascular inflammation contributes to the defence against invading microbes and to the repair of injured tissues. In most cases it resolves before becoming apparent. Vasculitis comprises heterogeneous clinical entities that are characterized by the persistence of vascular inflammation after it has served its homeostatic function. Most underlying mechanisms have so far remained elusive. Intravascular immunity refers to the surveillance of the vasculature by leucocytes that sense microbial or sterile threats to vessel integrity and initiate protective responses that entail most events that determine the clinical manifestations of vasculitis, such as end-organ ischaemia, neutrophil extracellular traps generation and thrombosis, leucocyte extravasation and degranulation. Understanding how the resolution of vascular inflammation goes awry in patients with systemic vasculitis will facilitate the identification of novel pharmacological targets and bring us a step closer in each patient to the selection of more effective and less toxic treatments.


Subject(s)
Blood Vessels/immunology , Systemic Vasculitis/immunology , Systemic Vasculitis/microbiology , B-Lymphocytes/immunology , Bacterial Infections/immunology , Blood Vessels/pathology , C-Reactive Protein/immunology , Humans , Inflammasomes/immunology , Serum Amyloid P-Component/immunology , T-Lymphocytes/immunology , Thrombosis/immunology , Thrombosis/pathology
4.
Parasite Immunol ; 31(12): 750-65, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19891613

ABSTRACT

The development of a protective immune response in sheep towards the presence of the larval stage of Lucilia cuprina has not been reported in the field. Upon investigation of the effects of larval excretory/secretory material on ovine T lymphocyte proliferation, we isolated a 56 kDa protein capable of inhibiting lymphocyte proliferation by at least 70%, compared with that in the presence of mitogen alone. This protein inhibited proliferation induced through cross-linking of the T-cell receptor as well as proliferation induced pharmacologically through the stimulation of the protein kinase C (PKC) pathway. The protein, named blowfly larval immunosuppressive protein (BLIP), was shown to bind directly to lymphocytes. Further investigation revealed that the BLIP prevented a proportion of lymphocytes from entering the first division following stimulation, by affecting the early events in lymphocyte activation. Subsequently, the BLIP reduced CD25 expression on T lymphocytes, reduced IL-2 mRNA expression, in addition to IFN-gamma, IL-4, IL-10 and IL-13 mRNA expression. Conversely, TNF-alpha and TGF-beta gene expression was up-regulated in response to the BLIP. These effects suggest suboptimal activation of T lymphocytes in the presence of the BLIP, and we propose that the BLIP presents an effective immune evasion tactic for the larvae of L. cuprina.


Subject(s)
Diptera/immunology , Insect Proteins/immunology , Myiasis/veterinary , Sheep Diseases/immunology , Sheep/parasitology , T-Lymphocytes/immunology , Adaptive Immunity , Amino Acid Sequence , Animals , Cell Proliferation , Cytokines/biosynthesis , Cytokines/genetics , Gene Expression Regulation , Insect Proteins/chemistry , Insect Proteins/genetics , Interleukin-2 Receptor alpha Subunit/genetics , Interleukin-2 Receptor alpha Subunit/metabolism , Larva/immunology , Lymphocyte Activation/genetics , Molecular Sequence Data , Myiasis/immunology , Myiasis/parasitology , Protein Binding , Sequence Alignment , Sheep/immunology , Sheep Diseases/parasitology
5.
Clin Exp Immunol ; 156(3): 395-404, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19309348

ABSTRACT

Vessel walls are the primary inflammatory sites in systemic vasculitides. In most cases the initiating event is unknown, and a self-sustaining circuit attracts and activates inflammatory leucocytes in the wall of vessels of various size and anatomical characteristics. Recent studies have revealed homeostatic roles of vascular inflammation and have identified the action of humoral innate immunity, in particular injury-associated signals and acute phase proteins, on the activation of circulating leucocytes, platelets and endothelial cells. These advances have provided clues to the molecular mechanisms underlying the vicious circle that maintains and amplifies vessel and tissue injury.


Subject(s)
Vasculitis/immunology , Blood Platelets/physiology , C-Reactive Protein/immunology , Endothelium, Vascular/immunology , Humans , Platelet Activation/immunology , Serum Amyloid P-Component/immunology , Vasculitis, Leukocytoclastic, Cutaneous/immunology
6.
J Thromb Haemost ; 4(12): 2593-8, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16959024

ABSTRACT

BACKGROUND: Polymorphonuclear leukocytes (PMN) from healthy subjects can produce and store tissue factor (TF), which is expressed on PMN surface upon in vitro stimulation with P-selectin. RESULTS: We report here that platelets and PMN from 12 patients with myeloproliferative disorders (MPD) (six with polycythemia vera, six with essential thrombocythemia) show up regulation of P-selectin and TF, respectively, in the absence of any in vitro challenge. The number of circulating mixed platelet-PMN aggregates was also increased. PMN TF expression as well as mixed platelet-PMN aggregates, but not platelet P-selectin, were significantly reduced in six MPD patients after treatment with hydroxyurea (HU). In vitro studies performed on PMN separated from healthy donors confirmed HU effects (0-1400 microm). HU prevented both P-selectin-induced TF expression and mixed cell aggregate formation. The inhibitory effect of HU was specific for P-selectin-induced PMN activation, as it did not affect formyl-methionyl-leucyl-phenylalanine-induced PMN TF expression. CONCLUSIONS: In MPD patients, platelet P-selectin-mediated TF expression on circulating PMN may play a role in thrombus formation and represents a novel target for the antithrombotic activity of HU.


Subject(s)
Fibrinolytic Agents/pharmacology , Hydroxyurea/pharmacology , Myeloproliferative Disorders/drug therapy , Neutrophils/drug effects , Thromboplastin/metabolism , Aged , Aged, 80 and over , Blood Platelets/drug effects , Blood Platelets/metabolism , Cell Aggregation/drug effects , Dose-Response Relationship, Drug , Female , Fibrinolytic Agents/therapeutic use , Humans , Hydroxyurea/therapeutic use , In Vitro Techniques , Male , Middle Aged , Myeloproliferative Disorders/metabolism , Neutrophils/metabolism , P-Selectin/metabolism , Platelet Adhesiveness/drug effects , Reference Values
7.
J Thromb Haemost ; 4(6): 1323-30, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16706978

ABSTRACT

BACKGROUND: Blood-borne tissue factor (TF) plays a crucial role in thrombogenesis. AIM: To study whether polymorphonuclear leukocytes (PMN) are a source of TF. METHODS AND RESULTS: Human PMN were carefully separated from other blood cells and stimulated for 3 min with purified P-selectin or the chemotactic peptide formyl-MetLeuPhe (fMLP): they expressed both TF procoagulant activity, as identified by specific TF MoAb and inactivated factor VIIa blockade; and TF:Ag (four to six times), as shown by flow-cytometry and immunocytochemistry. About 40% of permeabilized PMN, both resting and stimulated, contained TF:Ag, indicating that stimulation only modifies the location of TF:Ag within PMN. By real time-polymerase chain reaction (RT-PCR), a very low amount of TF mRNA was detectable in resting PMN, but a 3- to 5-fold increase was observed after 1-h stimulation with P-selectin or fMLP, respectively. CONCLUSIONS: These findings suggest that TF is not constitutively expressed in peripheral PMN, but can be up-regulated and produced upon stimulation and specific gene transcription, as for instance during contact with activated platelets or endothelium. The stored TF is rapidly expressed in vitro as a functional molecule on the surface of activated PMN. The availability of PMN TF supports the relevance of inflammatory cells and their interaction with platelets for fibrin deposition and thrombus formation.


Subject(s)
Blood Coagulation , Gene Expression Regulation , Neutrophils/metabolism , Thromboplastin/biosynthesis , Antibodies, Monoclonal , Cell Membrane/drug effects , Cell Membrane/metabolism , Flow Cytometry , Humans , Immunohistochemistry , In Vitro Techniques , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects , P-Selectin/pharmacology , Partial Thromboplastin Time , Protein Transport , RNA, Messenger/biosynthesis , Thromboplastin/genetics , Thromboplastin/immunology
9.
J Lab Clin Med ; 137(4): 261-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11283520

ABSTRACT

The present study investigated the effect of nitric oxide (NO) on megakaryocyte (Mk) proliferation induced by thrombopoietin (TPO). Low-density mononuclear cells (MNCs) and CD34+ cells from human bone marrow (BM) were cultured in liquid medium in the presence of sodium nitroprusside (SNP) or (Z)-1-[2-(aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate (DETA/NO) and then stimulated with TPO. Mk number decreased in both NO donors, as identified by flow cytometry 11 to 13 days after TPO stimulation. Nitrite, cyanide, or the carrier molecule DETA failed to reproduce the inhibition caused by NO donors. When CD34+ cells were treated with DETA/NO, the inhibition of Mk growth was even more pronounced than that in MNCs. Failure of the guanosine 3',5'-cyclic monophosphate (cGMP) analog 8-bromoguanosine 3',5'-cyclic monophosphate (8-Br-cGMP) to inhibit Mk proliferation suggests that cGMP is not involved in Mk suppression mediated by NO. On the other hand, DNA analysis by flow cytometry showed that apoptosis of CD34+ cells and Mks seemed to be at least one of the mechanisms associated with the cytotoxic DETA/NO effect. Stimulation of MNCs or CD34+ cells with tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) increased endogenous NO levels and suppressed Mk growth. Treatment with NO synthesis inhibitors such as L -N(G)-monomethyl arginine (L -NMMA) or L -N(G)-nitroarginine methyl ester hydrochloride (L -NAME) partially reversed Mk growth inhibition induced by TNF-alpha and IFN-gamma, although increased NO levels returned to normal values. The results presented here strongly indicate that NO regulates the growth of Mks induced by TPO by a direct effect on both progenitors and mature Mks.


Subject(s)
Cell Division/physiology , Megakaryocytes/cytology , Nitric Oxide/physiology , Thrombopoietin/pharmacology , Antigens, CD34/immunology , Apoptosis/physiology , Cell Division/drug effects , Flow Cytometry , Humans , Megakaryocytes/immunology
10.
Am J Hematol ; 65(2): 93-8, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10996824

ABSTRACT

There is convincing evidence that cell adhesion plays an important role in cardiovascular pathology and is frequently associated to "in vivo" cellular activation. This study involves patients with mechanical heart valve replacement (MHVR patients) who have increased platelet polymorphonuclear leukocyte (PMN) reactivity. Dual-color cytometry was used to determine the expression of adhesive molecules on cellular surfaces, platelet, and PMN-bound fibrinogen as well as the presence of circulating platelet/PMN mixed-cell aggregates (MCA) in 55 MHVR patients, 49 control patients under oral anticoagulant therapy, and 22 healthy volunteers. The results demonstrated that (a) PMN from MHVR patients showed an increased PMN-bound fibrinogen (mean +/- SEM: 1,420 +/- 169 anti-fibrinogen fluorescence intensity, P= 0.0012), when compared to controls (mean +/- SEM: 747 +/- 32 anti-fibrinogen fluorescence intensity) and healthy volunteers (mean +/- SEM: 692 +/- 25 anti-fibrinogen fluorescence intensity; (b) platelet activation in MHVR patients was evidenced by the higher expression of CD62P (mean +/- SEM: 128 +/- 19 anti-CD62P fluorescence intensity, P = 0.003) compared to controls (mean +/- SEM: 65 +/- 15 and 50 +/- 10 anti CD62P fluorescence intensity) and by increased levels of platelet-bound fibrinogen (mean +/- SEM: 625 +/- 20 anti-fibrinogen fluorescence intensity, P = 0.0043 versus 496 +/- 45 and 480 +/- 30 for control patients and for healthy volunteers, respectively); and (c) the proportion of MCA in MHVR patients (15 +/- 2%) was significantly higher (P = 0.009) compared to controls (7 + 1%) and healthy volunteers (6 +/- 2%). The results indicate that the presence of stable circulating MCA represents another marker of "in vivo" PMN activation in MHVR patients.


Subject(s)
Blood Platelets/physiology , Cell Adhesion , Heart Valve Prosthesis/adverse effects , Neutrophils/physiology , Adult , Aged , Blood Platelets/pathology , Cell Adhesion Molecules/blood , Female , Fibrinogen/metabolism , Flow Cytometry , Humans , Immunophenotyping , Male , Middle Aged , Neutrophils/pathology , Platelet Adhesiveness
11.
Thromb Haemost ; 77(1): 71-4, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9031452

ABSTRACT

Artificial surfaces activate blood components. Since anticoagulant and antiplatelet therapy fail to abolish thromboembolic complications in patients with mechanical heart valve replacement (MHVR), other mechanisms might contribute to switch on a thrombotic event. We therefore investigated the reactivity to chemotactic activation of PMN from patients with MHVR. PMN responses were analyzed in 3 groups: 130 patients with MHVR and oral anticoagulant therapy, with or without aspirin, 57 patients on a comparable antithrombotic regimen, but without MHVR and 50 healthy subjects. In vitro studies showed that the release of cathepsin G and elastase from fMLP-stimulated PMN was significantly higher in the MHVR group, the leukocyte content of alpha 1-antitrypsin (an inhibitor of both enzymes) being similar in all three groups. CD11b expression after stimulation with fMLP was also significantly higher on PMN from MHVR patients than from control patients or healthy volunteers, while PMN CD11b basal expression was similar in all three groups. This increased PMN response in vitro in the absence of an obvious activation in vivo, may reflect a modified reactivity of circulating PMN passing through the artificial valves. Increased reactivity to local stimuli might allow PMN to participate in thrombus formation, despite conventional antithrombotic therapy.


Subject(s)
Anticoagulants/administration & dosage , Aspirin/administration & dosage , Chemotaxis , Heart Valve Prosthesis/adverse effects , Neutrophils/pathology , Thrombosis/prevention & control , Cells, Cultured , Chemotaxis/drug effects , Female , Humans , Male , Middle Aged , Postoperative Complications/prevention & control
12.
Thromb Haemost ; 72(3): 450-6, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7531878

ABSTRACT

In PMN/platelet suspensions stimulated by fMLP giant mixed aggregates are formed and TxB2 and LTC4 are synthesized as the result of the cooperation in the arachidonic acid (AA) metabolism during cell/cell contact. PMN-derived cathepsin G induced the expression of P-selectin on platelet surface. GE12, an antibody against P-selectin, significantly reduced mixed cell aggregates. GE12 did not affect platelet aggregation induced by PMN-derived supernatants, indicating that the inhibitory effect of GE12 on mixed cell aggregation depends on inhibition of PMN/platelet adhesion. GE12 significantly reduced TxB2 and LTC4 production in PMN/platelet mixed cell suspensions stimulated by fMLP. As previously reported, synthesis of 3H-TxB2 in 3H-AA-labeled PMN/unlabeled platelets indicates that platelets utilize 3H-AA from PMN. 3H-LTC4 production in unlabeled PMN/3H-AA-labeled platelets indicates that bidirectional routes are utilized in this system for LTC4 synthesis. GE12 significantly reduced 3H-TxB2 and 3H-LTC4 synthesis. These results show that cathepsin G released by activated PMN induces the expression of P-selectin on platelet membrane: this adhesive glycoprotein modulates cell-cell contact and transcellular metabolism of AA.


Subject(s)
Blood Platelets/cytology , Leukotriene C4/biosynthesis , Neutrophils/cytology , Platelet Membrane Glycoproteins/physiology , Thromboxane B2/biosynthesis , Amino Acid Sequence , Arachidonic Acid/metabolism , Blood Platelets/metabolism , Carbohydrate Sequence , Cathepsin G , Cathepsins/physiology , Cell Adhesion , Cell Communication , Cytochalasin B/pharmacology , Gene Expression Regulation , Humans , Molecular Sequence Data , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects , Neutrophils/enzymology , P-Selectin , Serine Endopeptidases , Serotonin/metabolism
13.
Clin Exp Immunol ; 91(1): 164-9, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8419078

ABSTRACT

In the present study, we compared the ability of human neutrophils and monocytes to display oxygen-dependent cytotoxic responses at pH 7.4 and 6.2. Our results show that cytotoxicity induced by immune complexes (IC), zymosan, N-formyl-methionyl-leucyl-phenylalanine (FMLP) and concanavalin A (Con A) were markedly increased when they were carried out at pH 6.2 instead of pH 7.4. Cytotoxicity induced by phorbol myristate acetate (PMA), on the contrary, was significantly decreased at pH 6.2. It is noteworthy that cytotoxic responses induced by IC, zymosan and Con A were also increased when, 2 h after effector cell stimulation at pH 6.2, cytotoxicity was measured at pH 7.4. Finally, when we examined possible mechanisms involved in the augmentation of cytotoxicity, we observed that the oxidative response of IC-stimulated neutrophils, measured as chemiluminescence emission, was not increased at pH 6.2, on the contrary, it was significantly decreased. The relevance of these results is discussed.


Subject(s)
Cytotoxicity, Immunologic , Monocytes/immunology , Neutrophils/immunology , Oxygen/pharmacology , Antigen-Antibody Complex/immunology , Cells, Cultured , Humans , Hydrogen-Ion Concentration , Luminescent Measurements , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Tetradecanoylphorbol Acetate/pharmacology
14.
Blood ; 80(2): 447-51, 1992 Jul 15.
Article in English | MEDLINE | ID: mdl-1627802

ABSTRACT

Human polymorphonuclear leukocytes (PMN) activated by n-formyl-methionyl-leucyl-phenylalanine (fMLP), in the presence of cytochalasin B, are able to induce activation of coincubated autologous platelets "via" cathepsin G released from the azurophilic granules. However, thromboxane (Tx) B2 production in this system cannot be completely explained by cathepsin G-stimulated platelet arachidonate metabolism. Indeed, the amount of TxB2 found in supernatants of platelet/PMN suspensions challenged with 1 mumol/L fMLP was twofold to fourfold higher than that measured when platelets were stimulated by supernatants from fMLP-activated PMN. In the present report, we analyzed the possibility that PMN-induced TxB2 production in this system is the result of transcellular metabolism of arachidonic acid (AA) between fMLP-activated PMN and cathepsin G-stimulated platelets. 3H-AA-labeled PMN were used to test if a transfer of AA or metabolite(s) occur from PMN to platelets. Our results showed that: (1) 3H-TxB2 and 3H-12-HHT are synthesized when 3H-AA-labeled PMN are activated mixed to unlabeled platelets; (2) total radioactivity released by fMLP-stimulated PMN is increased in the presence of platelets, whereas the membrane content of unesterified 3H-AA is reduced; (3) platelet cyclooxygenase inhibition completely prevents 3H-TxB2 synthesis; and (4) inhibition of cathepsin G-induced platelet activation with the antiprotease eglin C blocks the formation of 3H-TxB2. These data show that in the experimental system used, platelets use PMN-derived unmetabolized AA to synthesize TxB2.


Subject(s)
Arachidonic Acids/blood , Blood Platelets/metabolism , Neutrophils/physiology , Platelet Activation , Thromboxane B2/blood , Blood Platelets/drug effects , Blood Platelets/physiology , Cathepsin G , Cathepsins/pharmacology , Cell Communication , Chromatography, High Pressure Liquid , Humans , Kinetics , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Platelet Activation/drug effects , Serine Endopeptidases
15.
Eur J Pharmacol ; 216(3): 401-5, 1992 Jun 17.
Article in English | MEDLINE | ID: mdl-1425930

ABSTRACT

Heparin is the most widely used anticoagulant drug for prevention and treatment of thrombosis. However, inhibition of blood coagulation might not fully explain the antithrombotic activity of this drug. The present study shows that different heparin preparations (50 nM) completely prevent human platelet aggregation, serotonin release and thromboxane B2 production induced by purified neutrophil-derived cathepsin G (E.C. No. 3.4.21.20). This inhibitory effect was not related to the anticoagulant property of the compounds, since a heparin preparation with an inactivated active for antithrombin III was also effective. Heparins inhibited the protease activity of the enzyme over the same range of concentrations. Since the effect of cathepsin G on platelets requires an intact proteolytic active site, the inhibitory effect of the drugs on cathepsin G-induced platelet activation may be explained by a blockade of protease activity. Heparins were also shown to reduce platelet activation induced by cathepsin G released from activated polymorphonuclear leucocytes in mixed cell suspensions. As polymorphonuclear leucocytes might contribute to both arterial and venous thrombosis through platelet activation induced by the release of cathepsin G, this novel property of heparin could be used to optimize its antithrombotic efficacy.


Subject(s)
Cathepsins/antagonists & inhibitors , Heparin/pharmacology , Platelet Activation/drug effects , Amino Acid Sequence , Cathepsin G , Humans , In Vitro Techniques , Molecular Sequence Data , Neutrophils/enzymology , Serine Endopeptidases , Serotonin/metabolism , Thromboxane B2/biosynthesis
17.
Am J Hematol ; 35(3): 208-9, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2220766

ABSTRACT

A boy with umbilical bleeding and severe hemorrhages after minor trauma, without family bleeding history, was studied. Coagulation tests showed abnormalities in FXIII subunits and FVIII/vWF complex. Both parents presented results compatible with a heterozygote state for FXIII deficiency and the father had abnormalities of FVIII/vWF. The propositus was diagnosed as congenital FXIII deficiency associated with vWD. No severe hemorrhagic complication was observed after a prophylactic regimen with cryoprecipitates.


Subject(s)
Factor XIII Deficiency/complications , von Willebrand Diseases/complications , Factor XIII Deficiency/blood , Factor XIII Deficiency/diagnosis , Female , Humans , Infant , Male , von Willebrand Diseases/blood , von Willebrand Diseases/diagnosis
19.
Thromb Res ; 56(1): 19-27, 1989 Oct 01.
Article in English | MEDLINE | ID: mdl-2512685

ABSTRACT

BAS is a protein generated by aortic rings isolated from rats. Our previous results clearly established that BAS inhibits platelet aggregation and modifies vascular tone. We have now examined the effect of separated segments of thoracic aorta and the effect of sex on the release of the BAS and PGI2. We evaluated three different segments of thoracic aorta: A = aortic arch, B = the upper segment and C = the lowest segment of the thoracic aorta. We measured the release of BAS and PGI2 from them. The BAS production increased in the first segment (A) when compared with the other two (B and C), whilst PGI2 production was the same along the thoracic aorta. On the other hand female and male thoracic aorta produced the same levels of BAS and 6-keto PGF1 cm.


Subject(s)
Aorta, Thoracic/metabolism , Epoprostenol/biosynthesis , Platelet Aggregation Inhibitors/metabolism , Protein Biosynthesis , Animals , Female , Humans , In Vitro Techniques , Male , Rats , Rats, Inbred Strains , Sex Factors
20.
Thromb Res ; 56(1): 13-8, 1989 Oct 01.
Article in English | MEDLINE | ID: mdl-2595671

ABSTRACT

Rat's vessel wall releases a protein named BAS (Bioactive Aortic Substance) whose antiaggregating effect on platelets and inotropy vascular properties have been already described. In this work we have investigated the effects of pregnancy, gonadectomy and gonadectomy with hormonal treatment on the BAS production from rat aortic rings. BAS production in pregnancy and ovariectomized rats was markedly decreased compared to normal rats. Return to normal values was obtained after estradiol treatment in ovariectomized rats. Castration resulted in an increased of BAS production which was suppressed by testosterone treatment.


Subject(s)
Aorta, Thoracic/metabolism , Estradiol/pharmacology , Platelet Aggregation Inhibitors/metabolism , Protein Biosynthesis , Testosterone/pharmacology , Animals , Castration , Female , In Vitro Techniques , Male , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...